Susan Cash, MD | |
590 W Ridge Rd Ste M, Wytheville, VA 24382-1067 | |
(276) 625-8870 | |
(276) 228-2010 |
Full Name | Susan Cash |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 30 Years |
Location | 590 W Ridge Rd Ste M, Wytheville, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780695320 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 0101269628 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wythe County Community Hospital | Wytheville, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healogics Specialty Physicians Of Virginia Llc | 1052637733 | 9 |
News Archive
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Statin medications, such as Crestor, Lipitor, and other lipid-lowering medications, have been prescribed increasingly in recent years to reduce cardiovascular disease and mortality in high risk individuals.
Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
› Verified 6 days ago
Entity Name | Healogics Specialty Physicians Of Virginia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689079055 PECOS PAC ID: 1052637733 Enrollment ID: O20150225000563 |
News Archive
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Statin medications, such as Crestor, Lipitor, and other lipid-lowering medications, have been prescribed increasingly in recent years to reduce cardiovascular disease and mortality in high risk individuals.
Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
› Verified 6 days ago
Entity Name | Integrated Wound Care Virginia Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407498397 PECOS PAC ID: 2365875390 Enrollment ID: O20191205002416 |
News Archive
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Statin medications, such as Crestor, Lipitor, and other lipid-lowering medications, have been prescribed increasingly in recent years to reduce cardiovascular disease and mortality in high risk individuals.
Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Susan Cash, MD 280 Chestnut Street, 2nd Floor, Springfield, MA 01199 Ph: (413) 794-5700 | Susan Cash, MD 590 W Ridge Rd Ste M, Wytheville, VA 24382-1067 Ph: (276) 625-8870 |
News Archive
The New York Times reports that "more than four decades after the surgeon general declared smoking a health hazard, the Senate on Thursday cleared the final hurdle to empowering federal officials to regulate cigarettes and other forms of tobacco for the first time.
Statin medications, such as Crestor, Lipitor, and other lipid-lowering medications, have been prescribed increasingly in recent years to reduce cardiovascular disease and mortality in high risk individuals.
Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
› Verified 6 days ago
Dr. Christopher Lee Downing, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1787 W Lee Hwy Ste 3, Wytheville, VA 24382 Phone: 276-228-1050 Fax: 855-352-6646 | |
Dalkeith George Facey, D.O. MBA Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 Spring Meadow Dr, Wytheville, VA 24382 Phone: 917-626-3666 | |
James Christopher Zwanch, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 590 W Ridge Rd, Suite D, Wytheville, VA 24382 Phone: 570-498-2799 |